|
1
|
Gut microbiome, obesity, and metabolic dysfunction.
|
J Clin Invest
|
2011
|
2.93
|
|
2
|
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.
|
J Immunol
|
2007
|
2.72
|
|
3
|
Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.
|
J Clin Invest
|
2006
|
2.16
|
|
4
|
Paneth cells as a site of origin for intestinal inflammation.
|
Nature
|
2013
|
2.09
|
|
5
|
Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
|
Gastroenterology
|
2004
|
2.02
|
|
6
|
ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells.
|
J Exp Med
|
2013
|
1.70
|
|
7
|
Genome-wide association analysis in primary sclerosing cholangitis.
|
Gastroenterology
|
2009
|
1.69
|
|
8
|
Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.
|
J Exp Med
|
2005
|
1.57
|
|
9
|
Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity.
|
Nat Med
|
2012
|
1.50
|
|
10
|
Clinical presentation of venous thromboembolism in inflammatory bowel disease.
|
J Crohns Colitis
|
2012
|
1.49
|
|
11
|
Cd1d-dependent regulation of bacterial colonization in the intestine of mice.
|
J Clin Invest
|
2009
|
1.49
|
|
12
|
CD1d function is regulated by microsomal triglyceride transfer protein.
|
Nat Med
|
2004
|
1.49
|
|
13
|
Obesity and the microbiota.
|
Gastroenterology
|
2009
|
1.49
|
|
14
|
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.
|
J Hepatol
|
2003
|
1.45
|
|
15
|
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.
|
Gut
|
2013
|
1.44
|
|
16
|
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms.
|
Immunity
|
2006
|
1.33
|
|
17
|
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression.
|
Gut
|
2010
|
1.30
|
|
18
|
Crohn's disease: NOD2, autophagy and ER stress converge.
|
Gut
|
2011
|
1.27
|
|
19
|
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.
|
Clin Immunol
|
2004
|
1.26
|
|
20
|
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
|
Gastroenterology
|
2010
|
1.23
|
|
21
|
Role of IL-10 for induction of anemia during inflammation.
|
J Immunol
|
2002
|
1.13
|
|
22
|
Treatment strategies in nonalcoholic fatty liver disease.
|
Nat Clin Pract Gastroenterol Hepatol
|
2005
|
1.13
|
|
23
|
Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells.
|
J Leukoc Biol
|
2003
|
1.12
|
|
24
|
Interferon-alpha controls IL-17 expression in vitro and in vivo.
|
Immunobiology
|
2008
|
1.07
|
|
25
|
Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.
|
J Clin Invest
|
2010
|
1.06
|
|
26
|
Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1.
|
Blood Cells Mol Dis
|
2003
|
1.03
|
|
27
|
How to modulate inflammatory cytokines in liver diseases.
|
Liver Int
|
2006
|
1.02
|
|
28
|
Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules.
|
J Immunol
|
2004
|
1.02
|
|
29
|
The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
|
J Hepatol
|
2005
|
1.01
|
|
30
|
Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis.
|
J Biol Chem
|
2014
|
0.98
|
|
31
|
Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
|
Am J Physiol Gastrointest Liver Physiol
|
2005
|
0.96
|
|
32
|
Novel insights into autoimmune liver diseases provided by genome-wide association studies.
|
J Autoimmun
|
2013
|
0.96
|
|
33
|
Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity.
|
Am J Physiol Gastrointest Liver Physiol
|
2007
|
0.95
|
|
34
|
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
|
Curr Opin Investig Drugs
|
2010
|
0.95
|
|
35
|
Endoplasmic reticulum stress and inflammation.
|
Dig Dis
|
2012
|
0.91
|
|
36
|
Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease.
|
Eur Cytokine Netw
|
2005
|
0.90
|
|
37
|
Intramural duodenal hematoma after upper gastrointestinal endoscopy.
|
Wien Med Wochenschr
|
2011
|
0.89
|
|
38
|
Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease.
|
Curr Opin Gastroenterol
|
2015
|
0.88
|
|
39
|
Endoplasmic reticulum stress and inflammatory bowel disease.
|
Acta Gastroenterol Belg
|
2011
|
0.88
|
|
40
|
Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.
|
J Clin Immunol
|
2002
|
0.87
|
|
41
|
DNA methylation analysis in the intestinal epithelium-effect of cell separation on gene expression and methylation profile.
|
PLoS One
|
2013
|
0.85
|
|
42
|
Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment.
|
J Virol
|
2003
|
0.83
|
|
43
|
Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
|
Eur Cytokine Netw
|
2005
|
0.83
|
|
44
|
A key role for Pre-B cell colony-enhancing factor in experimental hepatitis.
|
Hepatology
|
2011
|
0.83
|
|
45
|
Deciphering the genetic predisposition to primary sclerosing cholangitis.
|
Semin Liver Dis
|
2011
|
0.82
|
|
46
|
Monoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in mice.
|
Am J Transplant
|
2004
|
0.82
|
|
47
|
"ER stress(ed out)!": Paneth cells and ischemia-reperfusion injury of the small intestine.
|
Gastroenterology
|
2010
|
0.81
|
|
48
|
Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?
|
Eur Cytokine Netw
|
2009
|
0.81
|
|
49
|
Mode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseases.
|
Expert Opin Biol Ther
|
2007
|
0.80
|
|
50
|
Anti-IL-12/23 in Crohn's disease: bench and bedside.
|
Curr Drug Targets
|
2013
|
0.80
|
|
51
|
Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders.
|
Expert Opin Biol Ther
|
2004
|
0.79
|
|
52
|
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease.
|
Scand J Gastroenterol
|
2008
|
0.77
|
|
53
|
Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease.
|
Gastroenterology
|
2012
|
0.77
|
|
54
|
Controversy over NOD2, inflammation, and defensins.
|
Inflamm Bowel Dis
|
2010
|
0.77
|
|
55
|
Neurokinin-1 receptor interacts with PrP(106-126)-induced dendritic cell migration and maturation.
|
J Neuroimmunol
|
2005
|
0.77
|
|
56
|
Antitumour necrosis factor therapy in Crohn's disease.
|
Expert Opin Biol Ther
|
2002
|
0.76
|
|
57
|
Seventeen in Crohn's disease: less prime than we thought?
|
Gut
|
2012
|
0.76
|
|
58
|
Interferon-alpha suppresses leptin levels: studies in interferon-alpha treated patients with hepatitis C virus infection and murine adipocytes.
|
Eur Cytokine Netw
|
2002
|
0.76
|
|
59
|
Adiponectin and JNK: metabolic/inflammatory pathways affecting gastrointestinal carcinogenesis.
|
Gut
|
2009
|
0.75
|
|
60
|
Genetic insights into non-anastomotic biliary strictures after orthotopic liver transplantation.
|
Liver Int
|
2011
|
0.75
|
|
61
|
The other way round: colitis regulates regulatory T cells.
|
Gastroenterology
|
2004
|
0.75
|
|
62
|
Innate immunity in gastrointestinal disorders: basic and therapeutic concepts.
|
Dig Dis
|
2012
|
0.75
|
|
63
|
Message from the editors.
|
United European Gastroenterol J
|
2014
|
0.75
|
|
64
|
Introductory message from the Editors.
|
United European Gastroenterol J
|
2013
|
0.75
|